BGSF (BGSF)
(Delayed Data from NYSE)
$8.43 USD
+0.20 (2.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $8.51 +0.08 (0.95%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth D Momentum A VGM
Income Statements
Fiscal Year end for BGSF, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 313 | 298 | 239 | 278 | 294 |
Cost Of Goods | 201 | 195 | 158 | 202 | 214 |
Gross Profit | 112 | 104 | 81 | 76 | 81 |
Selling & Adminstrative & Depr. & Amort Expenses | 119 | 87 | 66 | 73 | 61 |
Income After Depreciation & Amortization | -7 | 16 | 15 | 4 | 20 |
Non-Operating Income | 0 | 0 | 0 | 0 | -1 |
Interest Expense | 6 | 1 | 1 | 2 | 2 |
Pretax Income | -13 | 15 | 13 | 2 | 18 |
Income Taxes | -3 | 4 | 3 | 1 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -10 | 11 | 10 | 1 | 13 |
Extras & Discontinued Operations | 0 | 14 | 4 | 0 | 0 |
Net Income (GAAP) | -10 | 25 | 14 | 1 | 13 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1 | 21 | 18 | 9 | 25 |
Depreciation & Amortization (Cash Flow) | 8 | 4 | 4 | 5 | 5 |
Income After Depreciation & Amortization | -7 | 16 | 15 | 4 | 20 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.76 | 10.48 | 11.24 | 10.29 | 10.35 |
Diluted EPS Before Non-Recurring Items | 0.81 | 1.26 | 0.98 | 1.34 | 1.67 |
Diluted Net EPS (GAAP) | -0.95 | 2.42 | 1.35 | 0.14 | 1.28 |
Fiscal Year end for BGSF, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 68.14 | 68.77 | 73.57 | 83.48 | 80.80 |
Cost Of Goods | 44.51 | 45.33 | 48.12 | 53.51 | 51.23 |
Gross Profit | 23.63 | 23.44 | 25.45 | 29.98 | 29.57 |
SG&A, R&D, and Dept/Amort Expenses | 23.55 | 23.03 | 22.22 | 24.71 | 24.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.08 | 0.41 | 3.23 | 5.27 | 5.05 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.06 | 1.24 | 1.60 | 1.67 | 1.50 |
Pretax Income | -0.98 | -0.82 | 1.63 | 3.60 | 3.55 |
Income Taxes | -0.22 | -0.03 | 0.63 | 0.96 | 0.94 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.76 | -0.79 | 1.00 | 2.64 | 2.60 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.76 | -0.79 | 1.00 | 2.64 | 2.60 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 10.88 | 10.83 | 9.08 | 10.80 | 10.77 |
Diluted EPS Before Non-Recurring Items | -0.07 | 0.07 | 0.11 | 0.36 | 0.24 |
Diluted Net EPS (GAAP) | -0.07 | -0.07 | 0.11 | 0.24 | 0.24 |